ANTENGENE-B's stock soared 7.65% during intraday trading on Tuesday, following the release of its annual financial results for the period ending December 31, 2025.

The company reported a 14.56% year-on-year increase in revenue to RMB 105 million, driven by accelerated contributions from Mainland China due to improving market penetration and deepening commercial collaborations. Additionally, research and development expenses decreased by 34.69% to RMB 169 million.

The annual loss narrowed by 25.10% to RMB 239 million, while the adjusted annual loss contracted by 23.50% to RMB 233 million. These improved financial metrics have bolstered investor confidence, leading to the significant price appreciation.